[Inappropriate antidiuretic hormone secretion syndrome associated with ramipril treatment].
Arroyo Domingo
E
E
Soriano Bel
A
A
Yuste Vila
D
D
Andreu Giménez
L
L
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D019338:Polypharmacy; D011188:Potassium / Q000627:therapeutic use; D017257:Ramipril / Q000009:adverse effects* / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D006852:Hydrochlorothiazide; D012965:Sodium Chloride; D017257:Ramipril; D011188:Potassium